Psychiatric Illness or Immune Dysfunction-Brain Perfusion Imaging Providing the Answer in a Case of Anti-NMDAR Encephalitis

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Oct 27

PMID 36292066

Authors

Ines Sisko Markos

Ivan Blazekovic

Vjekoslav Peitl

Tomislav Jukic

Visnja Supanc

Dalibor Karlovic

Ana Frobe

Affiliations

Soon will be listed here.

Abstract

Background: We investigated the potential use of SPECT quantification in addition to qualitative brain perfusion analysis for the detection of anti-NMDAR encephalitis. The question is how to normalize brain activity to be able to quantitatively detect perfusion patterns. Usually, brain activity is normalized to a structure considered unaffected by the disease.

Methods: Brain [99mTc]-HMPAO SPECT was performed as a method to detect brain perfusion patterns. The patterns of abnormal brain perfusion cannot always be reliably and qualitatively assessed when dealing with rare diseases. Recent advances in SPECT quantification using commercial software have enabled more objective and detailed analysis of brain perfusion. The cerebellum and whole brain were used as the normalization structures and were compared with visual analysis.

Results: The quantification analysis performed with whole brain normalization confirmed right parietal lobe hypoperfusion while also detecting statistically significant left-to-right perfusion differences between the temporal lobe and thalamus. Whole brain normalization further described bilateral frontal lobe hyperperfusion, predominantly of the left lobe, and was in accordance with visual analysis.

Conclusion: SPECT quantitative brain perfusion analysis, using the whole brain as the normalization structure rather than the cerebellum, in this case, improved confidence in the visual detection of anti-NMDAR encephalitis and provided unexpected solutions to atypical psychiatric dilemmas.

References

Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

Kerik-Rotenberg N, Diaz-Meneses I, Hernandez-Ramirez R, Munoz-Casillas R, Reynoso-Mejia C, Flores-Rivera J . A Metabolic Brain Pattern Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Psychosomatics. 2019; 61(1):39-48. DOI: 10.1016/j.psym.2019.08.007. View

Marcoux A, Burgos N, Bertrand A, Teichmann M, Routier A, Wen J . An Automated Pipeline for the Analysis of PET Data on the Cortical Surface. Front Neuroinform. 2019; 12:94. PMC: 6296445. DOI: 10.3389/fninf.2018.00094. View

Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M . Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2007; 70(7):504-11. PMC: 2586938. DOI: 10.1212/01.wnl.0000278388.90370.c3. View

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191-4. DOI: 10.1001/jama.2013.281053. View

Masdeu J, Dalmau J, Berman K . NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?. Trends Neurosci. 2016; 39(5):300-310. PMC: 5913742. DOI: 10.1016/j.tins.2016.02.006. View

Zandi M, Irani S, Lang B, Waters P, Jones P, McKenna P . Disease-relevant autoantibodies in first episode schizophrenia. J Neurol. 2010; 258(4):686-8. PMC: 3065649. DOI: 10.1007/s00415-010-5788-9. View

Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein H, Vielhaber S . Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor.... JAMA Psychiatry. 2013; 70(3):271-8. DOI: 10.1001/2013.jamapsychiatry.86. View

Matsumoto H, Hashida H, Takahashi Y . Dystonic Seizures and Intense Hyperperfusion of the Basal Ganglia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Case Rep Neurol. 2018; 9(3):272-276. PMC: 5836200. DOI: 10.1159/000484200. View

10.

Ito K, Shimano Y, Imabayashi E, Nakata Y, Omachi Y, Sato N . Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria. Int J Geriatr Psychiatry. 2014; 29(10):1079-86. DOI: 10.1002/gps.4102. View

11.

Dalmau J, Gleichman A, Hughes E, Rossi J, Peng X, Lai M . Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12):1091-8. PMC: 2607118. DOI: 10.1016/S1474-4422(08)70224-2. View

12.

Yamamoto S, Koide Y, Fujiwara M, Nakazawa K, Takahashi Y, Hara H . [Subacute encephalitis associated with anti-glutamate receptor antibodies: serial studies of MRI, 1H-MRS and SPECT]. Rinsho Shinkeigaku. 2008; 48(3):196-201. DOI: 10.5692/clinicalneurol.48.196. View

13.

Kavinga Gunawardane P, Grossman A . Phaeochromocytoma and Paraganglioma. Adv Exp Med Biol. 2016; 956:239-259. DOI: 10.1007/5584_2016_76. View

14.

Suarez J, Dominguez M, Gomez M, Portilla J, Gomez M, Casado I . Brain perfusion SPECT with Tc-HMPAO in the diagnosis and follow-up of patients with anti-NMDA receptor encephalitis. Neurologia (Engl Ed). 2016; 33(9):622-623. DOI: 10.1016/j.nrl.2016.05.019. View

15.

Pacak K, Wimalawansa S . Pheochromocytoma and paraganglioma. Endocr Pract. 2015; 21(4):406-12. DOI: 10.4158/EP14481.RA. View

16.

Kelley B, Patel S, Marin H, Corrigan J, Mitsias P, Griffith B . Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis. AJNR Am J Neuroradiol. 2017; 38(6):1070-1078. PMC: 7960083. DOI: 10.3174/ajnr.A5086. View

17.

Soonawala D, Amin T, Ebmeier K, Douglas Steele J, Dougall N, Best J . Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage. 2002; 17(3):1193-202. DOI: 10.1006/nimg.2002.1259. View

18.

Florance N, Davis R, Lam C, Szperka C, Zhou L, Ahmad S . Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009; 66(1):11-8. PMC: 2826225. DOI: 10.1002/ana.21756. View

19.

Peery H, Day G, Doja A, Xia C, Fritzler M, Foster W . Anti-NMDA receptor encephalitis in children: the disorder, its diagnosis, and treatment. Handb Clin Neurol. 2013; 112:1229-33. DOI: 10.1016/B978-0-444-52910-7.00045-3. View

20.

Iizuka T, Sakai F . [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology]. Brain Nerve. 2008; 60(9):1047-60. View